Iran Press/Iran News: Dr. Minoo Mohraz stated on Thursday that Iran was producing the 'COVIran Barakat' vaccine under the highest international standards and noted that Iran's pharmaceutical products had the necessary effect.
The first phase of the human trial's clinical studies of the first Iran-made COVID vaccine, named 'COVIran Barakat', began on December 29, 2020, on three volunteers.
According to the plans made, if the results of the first phase and the next phase's protocol are approved, the results of the second phase will be completed by May 21, 2021.
The second and third phases of this clinical study are to begin simultaneously.
104/216
Read more:
"COV Iran Barakat" vaccine is effective against British Coronavirus
Second, third phases of clinical study of COV Iran Barakat vaccine on agenda: Official
